HEADER HYDROLASE/HYDROLASE INHIBITOR 06-JUL-16 5KR2 TITLE PROTEASE PR5-SQV COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE PR5-SQV; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 83333 KEYWDS HIV-1 PROTEASE, E35D, SALT-BRIDGE INTERACTION, NATURAL POLYMORPHISM, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.LIU,K.M.POOLE,B.P.MAHON,R.MCKENNA,G.E.FANUCCI REVDAT 5 06-MAR-24 5KR2 1 COMPND HETNAM HETSYN REVDAT 4 04-DEC-19 5KR2 1 REMARK REVDAT 3 20-SEP-17 5KR2 1 JRNL REMARK REVDAT 2 16-NOV-16 5KR2 1 JRNL REVDAT 1 21-SEP-16 5KR2 0 JRNL AUTH Z.LIU,X.HUANG,L.HU,L.PHAM,K.M.POOLE,Y.TANG,B.P.MAHON,W.TANG, JRNL AUTH 2 K.LI,N.E.GOLDFARB,B.M.DUNN,R.MCKENNA,G.E.FANUCCI JRNL TITL EFFECTS OF HINGE-REGION NATURAL POLYMORPHISMS ON HUMAN JRNL TITL 2 IMMUNODEFICIENCY VIRUS-TYPE 1 PROTEASE STRUCTURE, DYNAMICS, JRNL TITL 3 AND DRUG PRESSURE EVOLUTION. JRNL REF J.BIOL.CHEM. V. 291 22741 2016 JRNL REFN ESSN 1083-351X JRNL PMID 27576689 JRNL DOI 10.1074/JBC.M116.747568 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.06 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 32217 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 22.0624 - 4.2803 0.96 2319 153 0.1791 0.1936 REMARK 3 2 4.2803 - 3.4015 0.96 2261 149 0.1629 0.1652 REMARK 3 3 3.4015 - 2.9727 0.95 2230 148 0.1955 0.2683 REMARK 3 4 2.9727 - 2.7014 0.94 2214 146 0.2183 0.2854 REMARK 3 5 2.7014 - 2.5081 0.94 2184 145 0.2166 0.2432 REMARK 3 6 2.5081 - 2.3604 0.93 2174 144 0.2115 0.2754 REMARK 3 7 2.3604 - 2.2423 0.93 2148 142 0.1977 0.2610 REMARK 3 8 2.2423 - 2.1447 0.92 2150 143 0.1841 0.2193 REMARK 3 9 2.1447 - 2.0622 0.91 2138 141 0.1800 0.2597 REMARK 3 10 2.0622 - 1.9911 0.91 2103 139 0.1892 0.2407 REMARK 3 11 1.9911 - 1.9289 0.90 2105 139 0.1800 0.2401 REMARK 3 12 1.9289 - 1.8738 0.90 2089 138 0.1755 0.2511 REMARK 3 13 1.8738 - 1.8245 0.90 2064 137 0.1958 0.2585 REMARK 3 14 1.8245 - 1.7800 0.87 2039 135 0.2434 0.3316 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.990 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3192 REMARK 3 ANGLE : 1.092 4338 REMARK 3 CHIRALITY : 0.045 516 REMARK 3 PLANARITY : 0.005 535 REMARK 3 DIHEDRAL : 13.314 1184 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KR2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1000222258. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM 7.1.1 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32248 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 26.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER 2.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.33500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 231 O HOH A 249 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: (2S)-N-[(2S,3R)-4-[(2S,3S,4AS,8AS)-3-(TERT- REMARK 630 BUTYLCARBAMOYL)-3,4,4A,5,6,7,8,8A-OCTAHYDRO-1H-ISOQUINOLIN-2-YL]-3- REMARK 630 HYDROXY-1 -PHENYL-BUTAN-2-YL]-2-(QUINOLIN-2-YLCARBONYLAMINO) REMARK 630 BUTANEDIAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 ROC A 101 REMARK 630 ROC C 101 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: QNC ASN HP0 NTB REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ROC A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ROC C 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5KQX RELATED DB: PDB REMARK 900 RELATED ID: 5KQY RELATED DB: PDB REMARK 900 RELATED ID: 5KQZ RELATED DB: PDB REMARK 900 RELATED ID: 5KR0 RELATED DB: PDB REMARK 900 RELATED ID: 5KR1 RELATED DB: PDB DBREF 5KR2 A 1 99 UNP V5YAB1 V5YAB1_9HIV1 1 99 DBREF 5KR2 B 1 99 UNP V5YAB1 V5YAB1_9HIV1 1 99 DBREF 5KR2 C 1 99 UNP V5YAB1 V5YAB1_9HIV1 1 99 DBREF 5KR2 D 1 99 UNP V5YAB1 V5YAB1_9HIV1 1 99 SEQADV 5KR2 LYS A 7 UNP V5YAB1 GLN 7 CONFLICT SEQADV 5KR2 ASN A 25 UNP V5YAB1 ASP 25 CONFLICT SEQADV 5KR2 ILE A 33 UNP V5YAB1 LEU 33 CONFLICT SEQADV 5KR2 LYS A 57 UNP V5YAB1 ARG 57 CONFLICT SEQADV 5KR2 ILE A 63 UNP V5YAB1 THR 63 CONFLICT SEQADV 5KR2 ALA A 67 UNP V5YAB1 CYS 67 CONFLICT SEQADV 5KR2 ALA A 95 UNP V5YAB1 CYS 95 CONFLICT SEQADV 5KR2 LYS B 7 UNP V5YAB1 GLN 7 CONFLICT SEQADV 5KR2 ASN B 25 UNP V5YAB1 ASP 25 CONFLICT SEQADV 5KR2 ILE B 33 UNP V5YAB1 LEU 33 CONFLICT SEQADV 5KR2 LYS B 57 UNP V5YAB1 ARG 57 CONFLICT SEQADV 5KR2 ILE B 63 UNP V5YAB1 THR 63 CONFLICT SEQADV 5KR2 ALA B 67 UNP V5YAB1 CYS 67 CONFLICT SEQADV 5KR2 ALA B 95 UNP V5YAB1 CYS 95 CONFLICT SEQADV 5KR2 LYS C 7 UNP V5YAB1 GLN 7 CONFLICT SEQADV 5KR2 ASN C 25 UNP V5YAB1 ASP 25 CONFLICT SEQADV 5KR2 ILE C 33 UNP V5YAB1 LEU 33 CONFLICT SEQADV 5KR2 LYS C 57 UNP V5YAB1 ARG 57 CONFLICT SEQADV 5KR2 ILE C 63 UNP V5YAB1 THR 63 CONFLICT SEQADV 5KR2 ALA C 67 UNP V5YAB1 CYS 67 CONFLICT SEQADV 5KR2 ALA C 95 UNP V5YAB1 CYS 95 CONFLICT SEQADV 5KR2 LYS D 7 UNP V5YAB1 GLN 7 CONFLICT SEQADV 5KR2 ASN D 25 UNP V5YAB1 ASP 25 CONFLICT SEQADV 5KR2 ILE D 33 UNP V5YAB1 LEU 33 CONFLICT SEQADV 5KR2 LYS D 57 UNP V5YAB1 ARG 57 CONFLICT SEQADV 5KR2 ILE D 63 UNP V5YAB1 THR 63 CONFLICT SEQADV 5KR2 ALA D 67 UNP V5YAB1 CYS 67 CONFLICT SEQADV 5KR2 ALA D 95 UNP V5YAB1 CYS 95 CONFLICT SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASN THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU ASP MET ASN LEU PRO SEQRES 4 A 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL LYS GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASN THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU ASP MET ASN LEU PRO SEQRES 4 B 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL LYS GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 C 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 C 99 LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASN THR SEQRES 3 C 99 GLY ALA ASP ASP THR VAL ILE GLU ASP MET ASN LEU PRO SEQRES 4 C 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 C 99 PHE ILE LYS VAL LYS GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 C 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 C 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 C 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 D 99 LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASN THR SEQRES 3 D 99 GLY ALA ASP ASP THR VAL ILE GLU ASP MET ASN LEU PRO SEQRES 4 D 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 D 99 PHE ILE LYS VAL LYS GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 D 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 D 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 D 99 GLN ILE GLY ALA THR LEU ASN PHE HET ROC A 101 49 HET ROC C 101 49 HETNAM ROC (2S)-N-[(2S,3R)-4-[(2S,3S,4AS,8AS)-3-(TERT- HETNAM 2 ROC BUTYLCARBAMOYL)-3,4,4A,5,6,7,8,8A-OCTAHYDRO-1H- HETNAM 3 ROC ISOQUINOLIN-2-YL]-3-HYDROXY-1 -PHENYL-BUTAN-2-YL]-2- HETNAM 4 ROC (QUINOLIN-2-YLCARBONYLAMINO)BUTANEDIAMIDE HETSYN ROC FORTOVASE; SAQUINAVIR; RO 31-8959 FORMUL 5 ROC 2(C38 H50 N6 O5) FORMUL 7 HOH *190(H2 O) HELIX 1 AA1 GLY A 86 THR A 91 1 6 HELIX 2 AA2 GLY B 86 ILE B 93 1 8 HELIX 3 AA3 GLY C 86 THR C 91 1 6 HELIX 4 AA4 GLY D 86 GLY D 94 1 9 SHEET 1 AA1 4 GLN A 2 ILE A 3 0 SHEET 2 AA1 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 AA1 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 AA1 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 AA2 8 TRP A 42 GLY A 49 0 SHEET 2 AA2 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 AA2 8 HIS A 69 GLY A 78 -1 O HIS A 69 N ILE A 66 SHEET 4 AA2 8 VAL A 32 GLU A 34 1 N ILE A 33 O LEU A 76 SHEET 5 AA2 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 AA2 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 AA2 8 LEU A 10 VAL A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 AA2 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 AA3 8 LYS B 43 GLY B 49 0 SHEET 2 AA3 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 AA3 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 AA3 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 AA3 8 ASN B 83 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 AA3 8 GLN B 18 LEU B 24 1 N LEU B 23 O ASN B 83 SHEET 7 AA3 8 LEU B 10 VAL B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 AA3 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 AA4 4 GLN C 2 ILE C 3 0 SHEET 2 AA4 4 THR D 96 ASN D 98 -1 O LEU D 97 N ILE C 3 SHEET 3 AA4 4 THR C 96 ASN C 98 -1 N ASN C 98 O THR D 96 SHEET 4 AA4 4 GLN D 2 THR D 4 -1 O ILE D 3 N LEU C 97 SHEET 1 AA5 8 TRP C 42 GLY C 49 0 SHEET 2 AA5 8 GLY C 52 ILE C 66 -1 O GLN C 58 N LYS C 43 SHEET 3 AA5 8 HIS C 69 GLY C 78 -1 O HIS C 69 N ILE C 66 SHEET 4 AA5 8 VAL C 32 GLU C 34 1 N ILE C 33 O LEU C 76 SHEET 5 AA5 8 ILE C 84 ILE C 85 -1 O ILE C 84 N VAL C 32 SHEET 6 AA5 8 GLN C 18 LEU C 24 1 N LEU C 23 O ILE C 85 SHEET 7 AA5 8 LEU C 10 VAL C 15 -1 N ILE C 13 O LYS C 20 SHEET 8 AA5 8 GLY C 52 ILE C 66 -1 O GLU C 65 N LYS C 14 SHEET 1 AA6 8 LYS D 43 GLY D 49 0 SHEET 2 AA6 8 GLY D 52 ILE D 66 -1 O GLY D 52 N GLY D 49 SHEET 3 AA6 8 HIS D 69 VAL D 77 -1 O HIS D 69 N ILE D 66 SHEET 4 AA6 8 VAL D 32 ILE D 33 1 N ILE D 33 O LEU D 76 SHEET 5 AA6 8 ILE D 84 ILE D 85 -1 O ILE D 84 N VAL D 32 SHEET 6 AA6 8 GLN D 18 LEU D 24 1 N LEU D 23 O ILE D 85 SHEET 7 AA6 8 LEU D 10 VAL D 15 -1 N ILE D 13 O LYS D 20 SHEET 8 AA6 8 GLY D 52 ILE D 66 -1 O GLU D 65 N LYS D 14 SITE 1 AC1 20 ASN A 25 GLY A 27 ALA A 28 ASP A 29 SITE 2 AC1 20 ASP A 30 ILE A 47 GLY A 48 GLY A 49 SITE 3 AC1 20 ILE A 50 THR A 80 PRO A 81 HOH A 223 SITE 4 AC1 20 HOH A 225 HOH A 227 ARG B 8 ASN B 25 SITE 5 AC1 20 GLY B 48 ILE B 50 PRO B 81 ILE B 84 SITE 1 AC2 19 ASN C 25 GLY C 27 ALA C 28 ASP C 29 SITE 2 AC2 19 ASP C 30 GLY C 48 GLY C 49 ILE C 50 SITE 3 AC2 19 THR C 80 PRO C 81 HOH C 215 HOH C 218 SITE 4 AC2 19 HOH C 219 ARG D 8 ASN D 25 GLY D 48 SITE 5 AC2 19 ILE D 50 PRO D 81 ILE D 84 CRYST1 50.890 62.670 58.400 90.00 98.59 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019650 0.000000 0.002968 0.00000 SCALE2 0.000000 0.015957 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017318 0.00000